Empowering transformative research and diagnostics with the power of proteomics

See how you can discover more

SomaLogic has revolutionized aptamer-based proteomics.

Our pioneering platform provides more coverage of the proteome than any other technology. With more coverage comes better insights, smarter decisions, improved outcomes, better healthcare. SomaLogic is an industry leader in proteomics, adding new analytes and developing innovative ways to advance your work every single day.

Healthcare Practitioners
Data and Analysis
 Icon of a microscope

Discover how the world’s leading life science and pharmaceutical research organizations are transforming their discovery and validation pipelines with our groundbreaking proteomic technologies.

Discover more

Healthcare Practitioners
Icon of connected circles with “+” inside each

Real-time health information that enables health systems to make better decisions and improve outcomes across their populations.

See the proteomics value proposition

Data and Analysis
Icon of a graph

Analyze and visualize all your studies in one clear, concise, and convenient view on the SomaLogic Life Sciences Portal. Combine study tracking with the power of statistical analysis and data visualization, and access our full menu of analytes.

Learn more

Industry-leading means…

We built the first and only platform that can simultaneously measure 7,000 proteins across a wide range of concentrations. Now we’re translating those measurements into key clinical indicators of health status and risk.

Hexagon with “7K” written inside

Largest menu

7,000 proteins per sample

Hexagon with 3 test tubes inside

Top tier facilities

CLIA-licensed ultra high-throughput lab

Hexagon with speedometer-like arrow pointed to the extreme right

Highly translational

Proteomics and clinical metrics from 55 μL of blood

Hexagon with a blue ribbon outline inside


20 years of innovation, >500 patents

Do you know the clues that proteogenomics reveals?

Illustration of a chromosome segment

Pairing large-scale protein measurements with next-generation sequencing and finding correlations via pQTLs can help researchers better connect the dots among genetic variations, disease, and druggable targets.

Download the white paper

For insights across multiple diseases


Researchers show how they’ve found hidden causal links between disease and genetic variations using proteomic analysis to identify relevant pQTLs


Carlos Cruchaga, PhD
B. Burton & R.M. Morris III Professor of Psychiatry
McDonnell Genome Institute
Washington University School of Medicine in St. Louis

The first multi-tissue study yielding hundreds of novel pQTLs. This data will be instrumental to identify the functional gene from GWAS signals, identify novel biological protein-protein interactions, and identify novel potential biomarkers and drug targets for complex traits.

Watch on-demand webinar

Portrait of Dr Sun

Benjamin Sun, PhD, MB, BChir
Royal Free Hospital
London, UK

Dr. Sun’s team at the University of Cambridge used the SomaScan Assay to develop a pQTL atlas of human plasma. They quantified 3,622 plasma proteins in 3,301 healthy participants and identified 1,927 pQTLs, 88 of which overlapped with disease susceptibility loci.

Watch on-demand webinar